P3 Health Partners regains Nasdaq compliance after failing minimum financial standards

Filed May 26, 2026 · Period ending May 20, 2026 · ~1 min read

Key Changes

• high

  Nasdaq confirmed on May 20, 2026 that P3 Health Partners has returned to compliance with continued listing requirements under Rule 5550(b)(2), resolving a deficiency first disclosed in November 2025.

  Item 3.01 verify on EDGAR →
• medium

  The company had previously failed to meet at least one of three minimum thresholds: $2.5 million stockholders' equity, $35 million market value of listed securities, or $500,000 net income from continuing operations.

  Item 3.01 verify on EDGAR →
• high

  The compliance restoration eliminates the immediate risk of delisting from Nasdaq, which would have severely impaired liquidity and institutional ownership.

  Item 3.01 verify on EDGAR →